Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (341-350 of 706) with videos related to

Pageof 71
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2018
Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein MetabolismDick C Chan, Gerald F Watts, Ransi Somaratne, et al.
Diabetes Care|August 10, 2007
Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levelsTheodore W K Ng, Gerald F Watts, P Hugh R Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2011
Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesityEsther M M Ooi, Gerald F Watts, Dennis L Sprecher, et al.
Trends in Pharmacological Sciences|September 26, 2018
MicroRNAs: Novel Molecular Targets and Response Modulators of Statin TherapyMohammad Mohajeri, Maciej Banach, Stephen L Atkin, et al.
Journal of Clinical Lipidology|April 25, 2017
Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemiaSven Bos, Michael Phillips, Gerald F Watts, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|January 23, 2022
Hypertriglyceridemia: rationale, design and implementation of the Australian Hypertriglyceridemia RegistryJing Pang, Stephen C H Li, Dick C Chan, et al.
Physiological Reports|November 1, 2016
Impact of commonly prescribed exercise interventions on platelet activation in physically inactive and overweight menAndrew Haynes, Matthew D Linden, Elisa Robey, et al.
Biochemical and Biophysical Research Communications|June 1, 2005
NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24Michael Hunter, Dora Angelicheva, Ivailo Tournev, et al.
Journal of Lipid Research|February 28, 2002
Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteinsKevin P Dwyer, P Hugh R Barrett, Dick Chan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 29, 2013
Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitusJing Pang, Dick C Chan, Sandra J Hamilton, et al.
Pageof 71

Showing results (341-350 of 706) with videos related to

Sort By:
Pageof 71
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2018
Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein MetabolismDick C Chan, Gerald F Watts, Ransi Somaratne, et al.
Diabetes Care|August 10, 2007
Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levelsTheodore W K Ng, Gerald F Watts, P Hugh R Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2011
Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesityEsther M M Ooi, Gerald F Watts, Dennis L Sprecher, et al.
Trends in Pharmacological Sciences|September 26, 2018
MicroRNAs: Novel Molecular Targets and Response Modulators of Statin TherapyMohammad Mohajeri, Maciej Banach, Stephen L Atkin, et al.
Journal of Clinical Lipidology|April 25, 2017
Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemiaSven Bos, Michael Phillips, Gerald F Watts, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|January 23, 2022
Hypertriglyceridemia: rationale, design and implementation of the Australian Hypertriglyceridemia RegistryJing Pang, Stephen C H Li, Dick C Chan, et al.
Physiological Reports|November 1, 2016
Impact of commonly prescribed exercise interventions on platelet activation in physically inactive and overweight menAndrew Haynes, Matthew D Linden, Elisa Robey, et al.
Biochemical and Biophysical Research Communications|June 1, 2005
NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24Michael Hunter, Dora Angelicheva, Ivailo Tournev, et al.
Journal of Lipid Research|February 28, 2002
Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteinsKevin P Dwyer, P Hugh R Barrett, Dick Chan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 29, 2013
Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitusJing Pang, Dick C Chan, Sandra J Hamilton, et al.
Pageof 71